Canaccord Genuity Initiates Vertex Pharmaceuticals At Buy By: Benzinga via Benzinga April 10, 2015 at 08:43 AM EDT Analysts at Canaccord Genuity initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) with a Buy rating. The ... Read More >> Related Stocks: Vertex Pharmaceuticals